resveratrol has been researched along with Ache in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 7 (30.43) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Kogure, Y; Mabuchi, M; Nakao, S; Noguchi, K; Shimizu, T; Tanaka, A; Wang, S | 1 |
| Ghasemnejad-Berenji, M; Nazari-Khanamiri, F | 1 |
| Hu, WP; Liu, TT; Qiu, CY; Wei, S | 1 |
| An, L; Han, T; Jin, M; Liu, F; Song, B; Wang, Z; Zhang, L; Zhang, X | 1 |
| Chiu, F; Gannon, FH; Hecht, JT; Hossain, MG; Mobed, C; Patra, D; Posey, KL; Veerisetty, AC | 1 |
| Crawford, J; Liu, S; Ma, Y; Shu, H; Tao, F; Xing, Y | 1 |
| Ding, J; Hao, M; Li, M; Li, Y; Tang, Q; Wang, B; Xie, M; Zhu, H | 1 |
| Ren, K | 1 |
| Evans, HM; Howe, PRC; Wong, RHX | 1 |
| Asiedu, MN; Burton, MD; Dussor, G; Hughes, T; Inyang, K; Lian, B; Mazhar, K; Mejia, GL; Price, TJ; Tillu, DV | 1 |
| Baron, G; Berenbaum, F; Boutron, I; Coudeyre, E; Nguyen, C; Poiraudeau, S; Rannou, F | 1 |
| Cheng, W; Fan, Q; Li, J; Liu, H; Lu, FF; Yan, CD; Yin, Q; Zhao, Y | 1 |
| Fang, JY; Han, B; Hoang, BX; Nimni, M; Shaw, DG | 1 |
| Cheng, Z; Dai, W; Deng, X; Han, Y; Hu, L; Jiang, C; Li, F; Liu, W; Pan, C; Song, H; Wu, X; Yang, Y; Zhang, G | 1 |
| Chen, YC; Wang, DP; Wang, ZM | 1 |
| Asiedu, MN; Dib-Hajj, SD; Dussor, G; Han, C; Price, TJ; Waxman, SG | 1 |
| Aggarwal, M; Katare, OP; Negi, P; Rathore, C; Sharma, G; Singh, B | 1 |
| Ambriz-Tututi, M; Granados-Soto, V; Rocha-González, HI | 1 |
| Boos, N; Kikuchi, S; Klawitter, M; Konno, S; Nerlich, A; Quero, L; Sekiguchi, M; Wuertz, K | 1 |
| Granados-Soto, V | 1 |
| Kim, HI; Kim, TH; Song, JH | 1 |
| Chopra, K; Kulkarni, SK; Sharma, S | 1 |
| Alonso-López, R; Asomoza-Espinosa, R; Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Torres-López, JE | 1 |
2 review(s) available for resveratrol and Ache
| Article | Year |
|---|---|
Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases.
Topics: Animals; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Pain; Phytoalexins; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes | 2008 |
Pleiotropic effects of resveratrol.
Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gene Expression; Isoenzymes; Neoplasms; Pain; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes | 2003 |
2 trial(s) available for resveratrol and Ache
| Article | Year |
|---|---|
Resveratrol supplementation reduces pain experience by postmenopausal women.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Double-Blind Method; Female; Humans; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Phytoestrogens; Postmenopause; Resveratrol; Stilbenes; Treatment Outcome | 2017 |
Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; France; Humans; Knee Joint; Osteoarthritis, Knee; Pain; Pain Measurement; Prospective Studies; Research Design; Resveratrol; Stilbenes; Treatment Outcome | 2017 |
19 other study(ies) available for resveratrol and Ache
| Article | Year |
|---|---|
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Topics: Analgesics; Animals; Calcium Channels; Ganglia, Spinal; HEK293 Cells; Humans; Inhibitory Concentration 50; Nerve Tissue Proteins; Pain; Patch-Clamp Techniques; Rats; Resveratrol; Stilbenes; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2017 |
Resveratrol may ameliorate rheumatoid arthritis via the STAT3/HIF-1/VEGF molecular pathway.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Inflammation; Pain; Resveratrol; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2022 |
Resveratrol inhibits the activity of acid-sensing ion channels in male rat dorsal root ganglion neurons.
Topics: Acid Sensing Ion Channels; Animals; Ganglia, Spinal; Male; Pain; Protons; Rats; Rats, Sprague-Dawley; Resveratrol; Sensory Receptor Cells | 2022 |
Resveratrol Ameliorates Trigeminal Neuralgia-Induced Cognitive Deficits by Regulating Neural Ultrastructural Remodelling and the CREB/BDNF Pathway in Rats.
Topics: Animals; Cognition; Cognitive Dysfunction; Elapid Venoms; Memory Disorders; Pain; Rats; Resveratrol; Trigeminal Neuralgia | 2022 |
Early Resveratrol Treatment Mitigates Joint Degeneration and Dampens Pain in a Mouse Model of Pseudoachondroplasia (PSACH).
Topics: Animals; Arthralgia; Inflammation; Mice; Mutation; Osteoarthritis; Pain; Resveratrol | 2023 |
Resveratrol alleviates temporomandibular joint inflammatory pain by recovering disturbed gut microbiota.
Topics: Animals; Gastrointestinal Microbiome; Humans; Inflammation; Mice; Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Temporomandibular Joint | 2020 |
Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling.
Topics: AMP-Activated Protein Kinases; Animals; Astrocytes; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Dynamins; Female; Hyperalgesia; Inflammation; Mitochondria; Mitochondrial Dynamics; Osteosarcoma; Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Spinal Cord | 2020 |
Commentary on Ma et al. Resveratrol brings back happy bug's harmony.
Topics: Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Pain; Resveratrol; Temporomandibular Joint | 2020 |
Pharmacological activation of AMPK inhibits incision-evoked mechanical hypersensitivity and the development of hyperalgesic priming in mice.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Cells, Cultured; Ganglia, Spinal; Hyperalgesia; Male; Metformin; Mice, Inbred ICR; Neurons; Pain; Pain Threshold; Postoperative Complications; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
Topics: Analgesics; Animals; Bone Neoplasms; CX3C Chemokine Receptor 1; Hyperalgesia; Injections, Spinal; Neuroglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Resveratrol; Stilbenes; Up-Regulation | 2014 |
Acidosis and Formaldehyde Secretion as a Possible Pathway of Cancer Pain and Options for Improved Cancer Pain Control.
Topics: Acidosis; Aldehyde Dehydrogenase; Dichloroacetic Acid; Formaldehyde; Glutathione; Humans; Hydrogen-Ion Concentration; Lactic Acid; Neoplasms; Pain; Pain Management; Quality of Life; Resveratrol; Sodium Bicarbonate; Stilbenes | 2015 |
Activation of Adenosine Monophosphate-activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain: Involvement of Inhibition on Mitogen-activated Protein Kinase.
Topics: AMP-Activated Protein Kinases; Animals; Bone Neoplasms; Cell Line, Tumor; Female; Humans; Inflammation; Mitogen-Activated Protein Kinases; Pain; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats.
Topics: Animals; Antioxidants; Cartilage, Articular; Cyclooxygenase 2; Cytokines; Extremities; Hyperalgesia; Iodoacetates; Male; Nitric Oxide Synthase Type II; Osteoarthritis; Pain; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Synovial Fluid | 2016 |
The AMPK Activator A769662 Blocks Voltage-Gated Sodium Channels: Discovery of a Novel Pharmacophore with Potential Utility for Analgesic Development.
Topics: AMP-Activated Protein Kinases; Analgesics; Anesthetics, Local; Animals; Binding Sites; Biphenyl Compounds; Drug Evaluation, Preclinical; HEK293 Cells; Hot Temperature; Humans; Male; meta-Aminobenzoates; Metformin; NAV1.7 Voltage-Gated Sodium Channel; Neural Conduction; Pain; Patch-Clamp Techniques; Pyrones; Rats; Rats, Sprague-Dawley; Reaction Time; Recombinant Fusion Proteins; Resveratrol; Sensory Receptor Cells; Sodium Channel Blockers; Stilbenes; Thiazoles; Thiophenes; Trigeminal Ganglion | 2017 |
Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Topics: Administration, Topical; Animals; Dialysis; Edema; Hydrogel, Polyethylene Glycol Dimethacrylate; Kinetics; Liposomes; Male; Pain; Particle Size; Rats, Wistar; Resveratrol; Rheology; Skin Absorption; Stilbenes; Surface-Active Agents; Suspensions | 2017 |
The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo.
Topics: Adult; Aged; Analgesics; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation; Humans; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Interleukin-8; Intervertebral Disc; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Middle Aged; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pain; Pain Measurement; Radiculopathy; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; Toll-Like Receptor 2; Wine; Young Adult | 2011 |
Resveratrol inhibits Na+ currents in rat dorsal root ganglion neurons.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ganglia, Spinal; Membrane Potentials; NAV1.7 Voltage-Gated Sodium Channel; Neural Inhibition; Neurons, Afferent; Neuropeptides; Nociceptors; Pain; Rats; Resveratrol; Sodium Channels; Stilbenes | 2005 |
Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Hot Temperature; Insulin; Male; Mice; Nitric Oxide; Pain; Pain Measurement; Phytotherapy; Plant Extracts; Plants, Medicinal; Resveratrol; Stilbenes; Streptozocin; Tumor Necrosis Factor-alpha | 2007 |
Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Female; Formaldehyde; Inflammation; Pain; Pyrazoles; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfonamides | 2002 |